All News

The US Preventive Services Task Force already has recommendations for screening and intervention for obesity, but they often are not followed.

Scaling behavioral change and reducing diabetes at the population level were major themes of the meeting.

This week, the top managed care stories included speculation regarding who would replace Tom Price, MD, as HHS secretary; a report on breast cancer mortality trends and racial disparities from 1989 to 2015; and the FDA announced new strategies to improve patient access to less expensive drugs.

The announcement does not affect LifeScan, which makes blood glucose management tools and apps. Company officials said an exclusivity deal between Medtronic and UnitedHealthcare was among the factors that contributed to the decision.

A new study in the journal BMJ concludes that most oncology drugs approved by the European Medicines Agency between 2009 and 2013 failed to display a benefit on survival or quality of life, even at 3.3 years following market entry.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

A research study conducted in a mouse mammary cancer model has found that optimal timing, based on sequencing of immunotherapy agents, is important for treatment efficacy.

The former CMS administrator, who coined the term "the Triple Aim," offered a vision for the next era of healthcare innovation at a summit presented by Horizon Blue Cross Blue Shield of New Jersey.

Patients who feel they have little control over their health are more likely to report being depressed as a result of pain they experience. Targeting a patient’s sense of control can improve outcomes and remove barriers to recovery for patients with pain.

The fight for dominance of the market for a costly cholesterol drug continues, even as sales fall short of expectations.

The recommendation is the first step toward making the therapy widely available to patients in England and Wales.

A new survey conducted by The Health Management Academy has identified a rapid investment by leading healthcare systems in precision medicine programs, with significant expectations of the impact of real-world outcomes on physician decision making.

Immune checkpoint inhibitors have become an important tool for treating cancer, but a new review finds their use is associated with a higher risk of endocrine dysfunctions like thyroid imbalances.

While the United States typically ranked first in rates of diagnosed conditions among 10 countries evaluated for patient insights into pressing health issues, it had the lowest work productivity impairment and activity impairment, according to a new report from Kantar Health.

Patients suffering from chronic obstructive pulmonary disease and their caretakers may experience symptoms of anxiety and depression that could impact their mortality, quality of life, and healthcare use.

The review of 28 studies found that night shift workers were at particularly high risk of developing the type of abdominal obesity associated with heart disease.

While death rates from breast cancer declined 39% from 1989 to 2015, there are clear racial differences with black women having higher breast cancer death rates than white women, according to a new report from the American Cancer Society.

Clinical trials researching cancer therapies should be more inclusive of a broader range of patients, according to the American Society of Clinical Oncology (ASCO) and Friends of Cancer Research.

The study was based on 12 years' worth of data from a national survey.

On consecutive days, the FDA announced 2 more strategies to help novel drugs reach more patients. One plan will encourage competition by providing more guidance to developers of complex generics, while the other will make it easier for physicians to treat patients with investigational products through the expanded access program.

The author, who has lived with type 1 diabetes for 16 years, offers practical advice on food, exercise, mindset, and sleep.

Individuals who develop neutropenia are at higher risk of infection, and they should understand the symptoms to look for that might mean they need to seek urgent medical care, explained Ruben A. Mesa, MD, of the Mayo Clinic.

Intuniv, a once-daily non-stimulant from Shire and Shionogi for adults with attention-deficit/hyperactivity disorder, met its primary endpoint and showed a superior change from baseline compared with placebo in a phase 3 study.

October is breast cancer awareness month, and as September ended, a new treatment received the FDA’s approval for advanced breast cancer and another was granted priority review for the adjuvant treatment of early breast cancer.

The filing also seeks new indications for fixed-dose combinations of canagliflozin and metformin.